16-3027170-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_024339.5(THOC6):c.700G>C(p.Val234Leu) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000364 in 1,614,132 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_024339.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
THOC6 | NM_024339.5 | c.700G>C | p.Val234Leu | missense_variant, splice_region_variant | 11/13 | ENST00000326266.13 | |
THOC6 | NM_001347704.2 | c.700G>C | p.Val234Leu | missense_variant, splice_region_variant | 12/14 | ||
THOC6 | NM_001347703.2 | c.628G>C | p.Val210Leu | missense_variant, splice_region_variant | 12/14 | ||
THOC6 | NM_001142350.3 | c.700G>C | p.Val234Leu | missense_variant, splice_region_variant | 11/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
THOC6 | ENST00000326266.13 | c.700G>C | p.Val234Leu | missense_variant, splice_region_variant | 11/13 | 1 | NM_024339.5 | P1 | |
THOC6 | ENST00000574549.5 | c.628G>C | p.Val210Leu | missense_variant, splice_region_variant | 12/14 | 1 | |||
THOC6 | ENST00000575576.5 | c.628G>C | p.Val210Leu | missense_variant, splice_region_variant | 11/13 | 5 | |||
THOC6 | ENST00000253952.9 | c.700G>C | p.Val234Leu | missense_variant, splice_region_variant | 11/12 | 2 |
Frequencies
GnomAD3 genomes ? AF: 0.000204 AC: 31AN: 152176Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000175 AC: 44AN: 251258Hom.: 0 AF XY: 0.000206 AC XY: 28AN XY: 135842
GnomAD4 exome AF: 0.000380 AC: 556AN: 1461838Hom.: 0 Cov.: 38 AF XY: 0.000358 AC XY: 260AN XY: 727216
GnomAD4 genome ? AF: 0.000204 AC: 31AN: 152294Hom.: 0 Cov.: 33 AF XY: 0.000215 AC XY: 16AN XY: 74456
ClinVar
Submissions by phenotype
THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome Pathogenic:1Uncertain:3
Uncertain significance, criteria provided, single submitter | research | Medgenome Labs Pvt Ltd | Feb 02, 2019 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München | Oct 21, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | May 06, 2021 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as 3C-VUS. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with Beaulieu-Boycott-Innes syndrome (MIM#613680). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from valine to leucine. (I) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD (v2) <0.01 for a recessive condition (49 heterozygotes, 0 homozygotes). (SP) 0309 - An alternative amino acid change at the same position has been observed in gnomAD (v2) (1 heterozygote, 0 homozygotes). (I) 0503 - Missense variant consistently predicted to be tolerated by multiple in silico tools or not conserved in placental mammals with a minor amino acid change. (SB) 0600 - Variant is located in the annotated WD5 repeat (PMID: 30476144). (I) 0705 - No comparable missense variants have previous evidence for pathogenicity. (I) 0802 - This variant has some previous evidence of pathogenicity in unrelated individuals. This variant has been previously reported as likely pathogenic, likely benign and as a VUS (ClinVar, LOVD, Decipher). It has also been reported as part of a haplotype in multiple patients with intellectual disability (PMID: 30476144, 31421288, 27295358). (SP) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) - |
not provided Pathogenic:1Uncertain:1
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 13, 2020 | Functional studies of the p.[W100R; G275D; V234L] haplotype suggest a damaging effect with abnormal nuclear localization and decreased interaction with protein partners from the THO complex, however, the V234L variant on its own did not affect nuclear localization nor interaction with protein partners (Mattioli et al., 2019); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 33144682, 31216405, 31421288, 30476144, 27295358, 26739162, 20503307, 23621916, 27102954, 15998806, 19059247, 11060033) - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 22, 2021 | The c.700G>C (p.V234L) alteration is located in coding exon 11 of the THOC6 gene. This alteration results from a G to C substitution at nucleotide position 700, causing the valine (V) at amino acid position 234 to be replaced by a leucine (L). Based on data from the Genome Aggregation Database (gnomAD) database, the THOC6 c.700G>C alteration was observed in 0.02% (49/282,608) of total alleles studied, with a frequency of 0.03% (36/129,008) in the European (non-Finnish) subpopulation. The c.298T>A (p.W100R), c.700G>C (p.V234L), and c.824G>A (p.G275D) alterations make up a known haplotype which was previously reported homozygous or compound heterozygous with another alteration in THOC1 in multiple patients with Beaulieu–Boycott–Innes syndrome (Casey, 2016; Mattioli, 2019; Gupta, 2020). The patients were reported to have intellectual disability, varying dysmorphic features, and other congenital anomalies including cardiac, genitourinary, renal, and skeletal malformations. The p.V234 amino acid is conserved in available vertebrate species. The p.V234L amino acid is located in a separate domain than the domains with the p.W100R and p.G275D amino acids and together may affect the functionality of the larger WD40 domain. Functional expression assays demonstrated that the c.(298T>A; 700G>C; 824G>C) haplotype in THOC6 alters THOC6 physiological nuclear localization and its interaction with other members of the THO complex, THOC1 and THOC5 and that the pathogenicity of the haplotype results from a combined effect of at least two of the three missense changes (Mattioli, 2019). The p.V234L alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, this alteration is classified as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at